Full text is available at the source.
Abstract
The 2023 Nobel Prize recognized the role of base modifications in advancing effective mRNA vaccines.
- Modern drug delivery technologies have been crucial for the success of RNA-based medicines.
- Lipid nanoparticles (LNPs) have enabled the clinical application of these therapies in less than a decade.
- Challenges in LNP design arise from complex interactions between lipids and RNA, as well as biological barriers.
- Understanding how protein corona formation affects in vivo performance is essential for LNP effectiveness.
- State-of-the-art strategies for LNP development include computational design and high-throughput screening.
Simplified